Group One Trading’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$178K	Sell	12,200 -21,100	-63%	-$337K	﹤0.01%	4209
2025 Q4	$256K	Buy	33,300 +11,700	+54%	+$92.3K	﹤0.01%	4145
2025 Q3	$159K	Buy	21,600 +6,900	+47%	+$35.3K	﹤0.01%	4916
2025 Q2	$58.8K	Sell	14,700 -52,100	-78%	-$190K	﹤0.01%	5441
2025 Q1	$212K	Sell	66,800 -99,200	-60%	-$467K	﹤0.01%	3961
2024 Q4	$888K	Buy	166,000 +163,000	+5,433%	+$1.22M	﹤0.01%	2677
2024 Q3	$15.8K	Buy	3,000 +800	+36%	+$2.87K	﹤0.01%	5365
2024 Q2	$4K	Sell	2,200 -1,700	-44%	-$3.17K	﹤0.01%	6038
2024 Q1	$6.94K	Sell	3,900 -400	-9%	-$835	﹤0.01%	6048
2023 Q4	$7.57K	Sell	4,300 -1,400	-25%	-$2.05K	﹤0.01%	6337
2023 Q3	$8.32K	Buy	5,700 +3,100	+119%	+$6.56K	﹤0.01%	6453
2023 Q2	$5.95K	Buy	+2,600	New	+$5.4K	﹤0.01%	6647
2022 Q3	–	Sell	-13,300	Closed	-$13K	–	7627
2022 Q2	$13K	Sell	13,300 -4,700	-26%	-$5.76K	﹤0.01%	6599
2022 Q1	$30K	Sell	18,000 -3,600	-17%	-$6.59K	﹤0.01%	6469
2021 Q4	$52K	Sell	21,600 -7,600	-26%	-$29.5K	﹤0.01%	6304
2021 Q3	$141K	Buy	29,200 +25,000	+595%	+$74K	﹤0.01%	5539
2021 Q2	$11K	Buy	4,200 +3,200	+320%	+$8.81K	﹤0.01%	7474
2021 Q1	$3K	Sell	1,000 -1,700	-63%	-$6.14K	﹤0.01%	7330
2020 Q4	$10K	Buy	2,700 +100	+4%	+$403	﹤0.01%	5778
2020 Q3	$10K	Buy	+2,600	New	+$10.4K	﹤0.01%	5420